Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Kidney Failure

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Kidney Failure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bonafè, R; Bussi, S; Coppo, A; Kirchin, MA; Maisano, F; Queliti, R; Tedoldi, F1
Bonnemain, B; Bruneval, P; Chevalier, T; Corot, C; Delaloge, F; Fabicki, JM; Factor, C; Fretellier, N; Idée, JM; Jestin-Mayer, G; Mayer, JF; Robic, C; Salhi, M; Schroeder, J; Siegmund, H1
Kameo, S; Kartamihardja, AA; Koyama, H; Nakajima, T; Tsushima, Y1
Kontopodis, E; Marias, K; Sakkalis, V; Spanakis, M; Van Cauter, S1

Other Studies

4 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Kidney Failure

ArticleYear
Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
    European radiology experimental, 2023, 03-01, Volume: 7, Issue:1

    Topics: Animals; Contrast Media; Creatinine; Gadolinium; Male; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Urea

2023
Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, May-25, Volume: 72

    Topics: Animals; Chelating Agents; Chemistry, Pharmaceutical; Contrast Media; Femur; Gadolinium; Heterocyclic Compounds; Kidney; Liver; Male; Myocardium; Organometallic Compounds; Rats, Wistar; Renal Insufficiency; Skin

2015
Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
    The British journal of radiology, 2016, Volume: 89, Issue:1066

    Topics: Animals; Brain; Contrast Media; Disease Models, Animal; Female; Gadolinium DTPA; Heterocyclic Compounds; Mice; Organometallic Compounds; Renal Insufficiency; Spectrophotometry, Atomic

2016
Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Journal of pharmacokinetics and pharmacodynamics, 2016, Volume: 43, Issue:5

    Topics: Brain; Brain Neoplasms; Cerebrovascular Circulation; Computer Simulation; Contrast Media; Female; Glioblastoma; Glomerular Filtration Rate; Healthy Volunteers; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Organometallic Compounds; Renal Insufficiency; Tissue Distribution

2016